Completed PHASE4 INTERVENTIONAL 2-arm NCT02060084

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

Sponsor: Wang Hua

Conditions Disorder of Stomach Function and Feeding Problems in Newborn Feeding and Eating Disorders of Childhood

Interventions a control group a probiotic-supplemented group

Updated 5 times since 2017 Last updated: Sep 4, 2016 Started: Jan 31, 2014 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02060084, this PHASE4 trial focuses on Disorder of Stomach Function and Feeding Problems in Newborn and Feeding and Eating Disorders of Childhood and remains completed. Sponsored by Wang Hua, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wang Hua

Data source: Kunshan First People's Hospital Affiliated to Jiangsu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kunshan, China